Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

VKTXVKTX

Showing 8 of 15 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in VIKING THERAPEUTICS INC

Yes. Bank of America holds 383,775 shares of VKTX (Viking Therapeutics), worth $15M, as of its Q2 2026 13F filing. It increased the position by 53,055 shares (+16.0%) from Q1 2026. Bank of America has held VKTX in every 13F on record since Q4 2022, 15 quarterly filings.

Current Value

$15M

Current Shares

383,775

Total Value Change

-$11.8M

Total Shares Change

-39,058

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
383,775
+16.0%
$15M0.0%$39.01
32
2026-Q1
Decreased
330,720
-4.6%
$10.8M0.0%$32.54
0
2025-Q4
Decreased
346,647
-40.0%
$12.2M0.0%$35.18
0
2025-Q3
Increased
578,268
+10.2%
$15.2M0.0%$26.28
31
2025-Q2
Increased
524,772
+45.1%
$13.9M0.0%$26.50
38
2025-Q1
Increased
361,710
+0.0%
$8.7M0.0%$24.15
27
2024-Q4
Decreased
361,551
-14.5%
$14.5M0.0%$40.24
0
2024-Q3
Decreased
422,833
-1.9%
$26.8M0.0%$63.31
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used